These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29468705)

  • 1. Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.
    Webb GJ; Rahman SR; Levy C; Hirschfield GM
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1213-1219. PubMed ID: 29468705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
    Prince MI; Burt AD; Jones DE
    Gut; 2002 Mar; 50(3):436-9. PubMed ID: 11839728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term rifampicin administration in primary biliary cirrhosis.
    Bachs L; Parés A; Elena M; Piera C; Rodés J
    Gastroenterology; 1992 Jun; 102(6):2077-80. PubMed ID: 1587427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of rifampicin in children with cholestatic pruritus.
    El-Karaksy H; Mansour S; El-Sayed R; El-Raziky M; El-Koofy N; Taha G
    Indian J Pediatr; 2007 Mar; 74(3):279-81. PubMed ID: 17401268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rifampicin in the treatment of pruritus in hepatic cholestasis.
    Gregorio GV; Ball CS; Mowat AP; Mieli-Vergani G
    Arch Dis Child; 1993 Jul; 69(1):141-3. PubMed ID: 8024298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin as treatment for pruritus in malignant cholestasis.
    Price TJ; Patterson WK; Olver IN
    Support Care Cancer; 1998 Nov; 6(6):533-5. PubMed ID: 9833303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Sertraline with Rifampin in the treatment of Cholestatic Pruritus: A Randomized Clinical Trial.
    Ataei S; Kord L; Larki A; Yasrebifar F; Mehrpooya M; Seyedtabib M; Hasanzarrini M
    Rev Recent Clin Trials; 2019; 14(3):217-223. PubMed ID: 30919782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase.
    Cançado EL; Leitão RM; Carrilho FJ; Laudanna AA
    Am J Gastroenterol; 1998 Sep; 93(9):1510-7. PubMed ID: 9732934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.
    Bachs L; Parés A; Elena M; Piera C; Rodés J
    Lancet; 1989 Mar; 1(8638):574-6. PubMed ID: 2564110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials.
    Khurana S; Singh P
    Liver Int; 2006 Oct; 26(8):943-8. PubMed ID: 16953834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
    Smith HT; de Souza AR; Thompson AH; McLaughlin MM; Dever JJ; Myers JA; Chen JV
    Dig Dis Sci; 2023 Jun; 68(6):2710-2730. PubMed ID: 36933112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pruritus of chronic cholestasis.
    Raiford DS
    QJM; 1995 Sep; 88(9):603-7. PubMed ID: 7583073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.
    Krawczyk M; Liebe R; Wasilewicz M; Wunsch E; Raszeja-Wyszomirska J; Milkiewicz P
    Liver Int; 2017 May; 37(5):743-747. PubMed ID: 27778443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
    Eaton JE; Nelson KM; Gossard AA; Carey EJ; Tabibian JH; Lindor KD; LaRusso NF
    Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678
    [No Abstract]   [Full Text] [Related]  

  • 17. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial.
    Kuiper EM; van Erpecum KJ; Beuers U; Hansen BE; Thio HB; de Man RA; Janssen HL; van Buuren HR
    Hepatology; 2010 Oct; 52(4):1334-40. PubMed ID: 20683930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenobarbital effects in cholestatic liver diseases.
    Bloomer JR; Boyer JL
    Ann Intern Med; 1975 Mar; 82(3):310-7. PubMed ID: 1115464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
    Beuers U; Wolters F; Oude Elferink RPJ
    Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked Increase of Gamma-Glutamyltransferase as an Indicator of Drug-Induced Liver Injury in Patients without Conventional Diagnostic Criteria of Acute Liver Injury.
    Weber S; Allgeier J; Denk G; Gerbes AL
    Visc Med; 2022 Jun; 38(3):223-228. PubMed ID: 35814980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.